Clinical Trial Update: Methylphenidate for Attention Problems After Pediatric TBI [Phase 4]

View source ↗

Summary

Phase 4 trial assessing methylphenidate for attention problems after pediatric traumatic brain injury has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Traumatic Brain Injury

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Traumatic Brain Injury, TBI | Phase 4 | Status: COMPLETED | Results posted: 2020-06-04